- SARS-CoV-2 and COVID-19 Research
- COVID-19 and Mental Health
- Psychology of Moral and Emotional Judgment
- Cerebral Palsy and Movement Disorders
- Infant Development and Preterm Care
- Thermal Regulation in Medicine
- COVID-19 epidemiological studies
- COVID-19 Clinical Research Studies
- Cognitive Science and Mapping
Scripps (United States)
2024
University of Missouri–Kansas City
2024
Scripps Institution of Oceanography
2024
Scripps Research Institute
2022-2023
Abstract Background The uptake of nirmatrelvir plus ritonavir (NPR) in patients with coronavirus disease 2019 (COVID-19) has been limited by concerns around the rebound phenomenon despite scarcity evidence its epidemiology. purpose this study was to prospectively compare epidemiology NPR-treated and untreated participants acute COVID-19 infection. Methods We designed a prospective, observational which who tested positive for were clinically eligible NPR recruited be evaluated either viral or...
Abstract Introduction The uptake of Paxlovid in individuals infected with COVID-19 has been significantly limited by concerns around the rebound phenomenon despite scarcity evidence its epidemiology. purpose this study was to prospectively compare epidemiology treated and untreated participants acute infection Methods We designed a decentralized, digital, prospective observational which who tested positive for using eMed Test-to-Treat telehealth kits were clinically eligible recruited be...
<title>Abstract</title> Observation of COVID-19 rebound after Nirmatrelvir Plus Ritonavir (NPR) has driven important questions surrounding one the only direct acting antiviral treatments for COVID-19. This prospective cohort study to investigate incidence enrolled 917 positive outpatients via a digital proctored test-to-treat solution. Among 669 included in evaluation 493 intended take NPR and 176 did not. Participants were provided frequent tests symptom surveys 15 days. Time initial viral...
The purpose of this article is to report on the lessons learned from parents and caregivers school-age children with intellectual developmental disabilities (IDD) in Missouri Maryland regarding facilitators barriers SARS-COV-2 testing.